Bond Screener
IQVIA Inc.
LEI 549300PLWY28YB00C717
Organization name
IQVIA Inc.
Country name
USA
Country of registration
USA
Industry
Professional Services
Credit Ratings
in foreign currency
Public debt
6,236 mln USD
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access
-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
IQVIA Inc. develops, produces, and retails pharmaceutical products. The Company offers medicines for cardiovascular, diabetes, endocrinology, infestious diseases, oncology, pediatrics, and vaccines. Quintiles Transnational markets its products worldwide.
|
General information
-
Organization nameIQVIA Inc.
-
Organization statusOperating organization
-
Address83 Wooster Heights Road Danbury, USA, 06810
-
Site
News
Affiliates
Stocks
Bond classification
- Organization does not disclose IFRS/US GAAP financial statements
General information
-
Organization nameIQVIA Inc.
-
Organization statusOperating organization
-
Address83 Wooster Heights Road Danbury, USA, 06810
-
Site
Codes
-
LEI549300PLWY28YB00C717
-
SIC8731 SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
-
NAICS541,715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and
